Good news for 2027: Zedira keeps prices stable

 
Dear valued customers,
 
As we approach the end of another exciting year, we would like to thank you for your trust, collaboration, and continued support. It is a privilege to contribute to your scientific projects and innovations in transglutaminase research and related fields.
 
At Zedira, our mission remains unchanged: We catalyze transglutaminase research. Through our portfolio of approximately 250 specialty reagents, enzymes, diagnostic antigens, and innovative solutions such as Andracon® microbial transglutaminase, we continue to support researchers in academia and industry worldwide.
 
Stable pricing for 2027
In times of persistent inflation, rising operational costs, and increasing budget constraints across the research sector, we are pleased to share some positive news:
Zedira will maintain stable pricing throughout 2027.

We believe that sustainable growth does not necessarily have to come from higher prices. Instead, we continuously invest in improving efficiency, optimizing processes, and strengthening our operations so that we can continue delivering the quality, reliability, and service you expect from us while keeping our products accessible.

We are particularly aware of the financial pressures faced by many academic institutions, biotechnology companies, and pharmaceutical organizations. By keeping our prices stable, we aim to provide greater predictability for your project planning and budgeting.
 
Let's plan 2027 together
Whether you are preparing new research projects, scaling development activities, or planning future purchasing needs, our team is here to support you.
Contact us at contact@zedira.com to request a quotation, discuss product suitability for your application, or share your expected demand for 2027 so that we can help ensure optimal availability and planning.
 
Thank you for your continued trust in Zedira. We look forward to supporting your scientific success in the coming year.

 
Sincerely,

Your Zedira-Team